BIO-TECHNE Corp — Director's Dealing 2022

Dec 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2022-12-07

Reporting Person: Furlow Brenda S. (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-12-07	Common Stock	M	800	$31.2625	Acquired	26892	Direct
2022-12-07	Common Stock	S	800	$82.0063	Disposed	26092	Direct
2022-12-08	Common Stock	M	7450	$31.2625	Acquired	33542	Direct
2022-12-08	Common Stock	S	7450	$82.1222	Disposed	26092	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-12-07	Stock Options (Right to Buy)	$31.2625	M	800	Disposed	2024-08-09	Common Stock (800)	Direct
2022-12-08	Stock Options (Right to Buy)	$31.2625	M	7450	Disposed	2024-08-09	Common Stock (7450)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	5320	Indirect
Common Stock	5320	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options (Right to Buy)	$44.3300	2025-08-08	Common Stock (66248)	66248	Direct
Stock Options (Right to Buy)	$47.6025	2026-08-07	Common Stock (39872)	39872	Direct
Stock Options (Right to Buy)	$47.6025	2026-08-07	Common Stock (53160)	53160	Direct
Restricted Stock Units	$		Common Stock (6716)	6716	Direct
Stock Options (Right to Buy)	$66.9675	2027-08-05	Common Stock (29968)	29968	Direct
Stock Options (Right to Buy)	$66.9675	2027-08-05	Common Stock (39960)	39960	Direct
Stock Options (Right to Buy)	$66.9675	2027-08-05	Common Stock ()		Direct
Stock Options (Right to Buy)	$66.9675	2027-08-05	Common Stock (33300)	33300	Direct
Stock Options (Right to Buy)	$93.1100	2028-03-01	Common Stock (43988)	43988	Direct
Restricted Stock Units	$		Common Stock (4668)	4668	Direct
Stock Options (Right to Buy)	$120.4550	2028-08-06	Common Stock (18240)	18240	Direct
Stock Options (Right to Buy)	$120.4550	2028-08-06	Common Stock (24320)	24320	Direct
Stock Options (Right to Buy)	$94.5200	2029-08-15	Common Stock (24664)	24664	Direct
Restricted Stock Units	$		Common Stock (7936)	7936	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from 82.0000 to 82.4900, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2: Fully exercisable.

F3: Options to purchase13,292 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 13,288 shares vest on each of 8/7/2022 and 8/7/2023.

F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F5: Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: Options to purchase 9,992 shares vest on each of 8/5/2021 and 8/5/2022 and options to purchase 9,988 shares vest on each of 8/5/2023 and 8/5/2024.

F7: Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.

F8: Options to purchase 11,100 shares vest on each of 8/5/2021, 8/5/2022 and 8/5/2023.

F9: Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F10: Options to purchase 6,080 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.

F11: Options to purchase 6,168 shares vest on each of 8/15/2023 and 8/15/2025 and options to purchase 6,164 shares vest on 8/15/2024 and 8/15/2026.

F12: 2,644 shares vest on each of 8/15/2023 and 8/15/2025, and 2,648 shares vest on 8/15/2024.